Human Genome Sciences, Inc. (HGSI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steven Rachbach who wrote (567)	5/4/2001 10:55:31 AM
From: John Lacelle	of 1127

Steven, Before we fall head over heals with this one we should remember a few things. This whole Human Genome stuff is way over blown. Just because you know the sequence of the human genome does not mean you can cure every disease known to man (despite some of the bizarre claims by some in the industry). Currently, it takes about 100 million dollars to bring a drug to market. This process can take a decade. I'll give you an example. For over 10 years we have known the structure of HIV reverse transcriptase. The HIV virus needs this enzyme to infect a human cell. Yet even though we know the sequence, we know the structure of the protein, and even though this is public information that would be worth billions of dollars to anyone who can create a drug that inhibits or destroys HIV reverse transcriptase, nobody has been able to do this. Its not such an easy thing to go from gene => drug => cure. I think that HGSI is a highly speculative company. -John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next